APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

279 hedge funds and large institutions have $7.28B invested in Apellis Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 106 increasing their positions, 78 reducing their positions, and 28 closing their positions.

Holders
279
Holders Change
+36
Holders Change %
+14.81%
% of All Funds
4.47%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.21%
New
67
Increased
106
Reduced
78
Closed
28
Calls
$182M
Puts
$106M
Net Calls
+$75.5M
Net Calls Change
+$49.7M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$124M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$303M
3
O
3
OrbiMed
New York
$60M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$309M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$140M

Top Sellers

1
LGM
1
Logos Global Management
California
$52.8M
2
State Street
2
State Street
Massachusetts
$197M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$546M
4
Goldman Sachs
4
Goldman Sachs
New York
$43.7M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$6.1M
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$733M 11,111,111 +486,111 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$629M 9,528,944 +316,453 +3%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$546M 8,278,439 -479,222 -5%
BlackRock
4
BlackRock
New York
$505M 7,655,451 -48,743 -0.6%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$380M 5,760,664 -81,996 -1%
EC
6
EcoR1 Capital
California
$360M 5,451,647 +268,216 +5%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$309M 4,681,482 +693,737 +17%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$303M 4,590,040 +1,840,498 +67%
OCA
9
Octagon Capital Advisors
New York
$214M 3,250,000 +90,000 +3%
State Street
10
State Street
Massachusetts
$197M 2,979,862 -492,052 -14%
Jennison Associates
11
Jennison Associates
New York
$172M 2,612,767 +97,450 +4%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$140M 2,125,437 +665,274 +46%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$124M 1,879,724 +1,879,724 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$121M 1,838,279 +88,278 +5%
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$109M 1,648,452 -198,857 -11%
BC
16
Boxer Capital
California
$104M 1,576,000 – –
Macquarie Group
17
Macquarie Group
Australia
$93.1M 1,411,479 -50,163 -3%
CAM
18
Cormorant Asset Management
Massachusetts
$89.7M 1,360,000 -216,872 -14%
AG
19
Artal Group
Luxembourg
$80.2M 1,216,312 +316,312 +35%
BG
20
Bellevue Group
Switzerland
$73.2M 1,109,382 +5,165 +0.5%
Invesco
21
Invesco
Georgia
$68.7M 1,040,981 +540,194 +108%
Charles Schwab
22
Charles Schwab
California
$64.9M 983,509 +582 +0.1%
Norges Bank
23
Norges Bank
Norway
$61.4M 931,510 -115,944 -11%
O
24
OrbiMed
New York
$60M 910,200 +910,200 New
Lord, Abbett & Co
25
Lord, Abbett & Co
New Jersey
$59.6M 904,228 -228,395 -20%
1
2 3 4 5